Minimum information required for a DMET experiment reporting

Judit Kumuthini, Mamana Mbiyavanga, Emile R. Chimusa, Jyotishman Pathak, Panu Somervuo, Ron HN Van Schaik, Vita Dolzan, Clint Mizzi, Kusha Kalideen, Raj S. Ramesar, Milan Macek, George P. Patrinos, Alessio Squassina

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: To provide pharmacogenomics reporting guidelines, the information and tools required for reporting to public omic databases. Material & methods: For effective DMET data interpretation, sharing, interoperability, reproducibility and reporting, we propose the Minimum Information required for a DMET Experiment (MIDE) reporting. Results: MIDE provides reporting guidelines and describes the information required for reporting, data storage and data sharing in the form of XML. Conclusion: The MIDE guidelines will benefit the scientific community with pharmacogenomics experiments, including reporting pharmacogenomics data from other technology platforms, with the tools that will ease and automate the generation of such reports using the standardized MIDE XML schema, facilitating the sharing, dissemination, reanalysis of datasets through accessible and transparent pharmacogenomics data reporting.

Original languageEnglish (US)
Pages (from-to)1533-1545
Number of pages13
JournalPharmacogenomics
Volume17
Issue number14
DOIs
StatePublished - Sep 1 2016

Fingerprint

Pharmacogenetics
Information Dissemination
Guidelines
Research Design
Information Storage and Retrieval
Databases
Technology

Keywords

  • bioinformatics
  • DMET
  • minimum information requirement guidelines
  • personalized genomics
  • personalized medicine
  • pharmacogenomics
  • standardization

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this

Kumuthini, J., Mbiyavanga, M., Chimusa, E. R., Pathak, J., Somervuo, P., Van Schaik, R. HN., ... Squassina, A. (2016). Minimum information required for a DMET experiment reporting. Pharmacogenomics, 17(14), 1533-1545. https://doi.org/10.2217/pgs-2016-0015

Minimum information required for a DMET experiment reporting. / Kumuthini, Judit; Mbiyavanga, Mamana; Chimusa, Emile R.; Pathak, Jyotishman; Somervuo, Panu; Van Schaik, Ron HN; Dolzan, Vita; Mizzi, Clint; Kalideen, Kusha; Ramesar, Raj S.; Macek, Milan; Patrinos, George P.; Squassina, Alessio.

In: Pharmacogenomics, Vol. 17, No. 14, 01.09.2016, p. 1533-1545.

Research output: Contribution to journalArticle

Kumuthini, J, Mbiyavanga, M, Chimusa, ER, Pathak, J, Somervuo, P, Van Schaik, RHN, Dolzan, V, Mizzi, C, Kalideen, K, Ramesar, RS, Macek, M, Patrinos, GP & Squassina, A 2016, 'Minimum information required for a DMET experiment reporting', Pharmacogenomics, vol. 17, no. 14, pp. 1533-1545. https://doi.org/10.2217/pgs-2016-0015
Kumuthini J, Mbiyavanga M, Chimusa ER, Pathak J, Somervuo P, Van Schaik RHN et al. Minimum information required for a DMET experiment reporting. Pharmacogenomics. 2016 Sep 1;17(14):1533-1545. https://doi.org/10.2217/pgs-2016-0015
Kumuthini, Judit ; Mbiyavanga, Mamana ; Chimusa, Emile R. ; Pathak, Jyotishman ; Somervuo, Panu ; Van Schaik, Ron HN ; Dolzan, Vita ; Mizzi, Clint ; Kalideen, Kusha ; Ramesar, Raj S. ; Macek, Milan ; Patrinos, George P. ; Squassina, Alessio. / Minimum information required for a DMET experiment reporting. In: Pharmacogenomics. 2016 ; Vol. 17, No. 14. pp. 1533-1545.
@article{789b16cdd0934f628b55c7eb8bc5198f,
title = "Minimum information required for a DMET experiment reporting",
abstract = "Aim: To provide pharmacogenomics reporting guidelines, the information and tools required for reporting to public omic databases. Material & methods: For effective DMET data interpretation, sharing, interoperability, reproducibility and reporting, we propose the Minimum Information required for a DMET Experiment (MIDE) reporting. Results: MIDE provides reporting guidelines and describes the information required for reporting, data storage and data sharing in the form of XML. Conclusion: The MIDE guidelines will benefit the scientific community with pharmacogenomics experiments, including reporting pharmacogenomics data from other technology platforms, with the tools that will ease and automate the generation of such reports using the standardized MIDE XML schema, facilitating the sharing, dissemination, reanalysis of datasets through accessible and transparent pharmacogenomics data reporting.",
keywords = "bioinformatics, DMET, minimum information requirement guidelines, personalized genomics, personalized medicine, pharmacogenomics, standardization",
author = "Judit Kumuthini and Mamana Mbiyavanga and Chimusa, {Emile R.} and Jyotishman Pathak and Panu Somervuo and {Van Schaik}, {Ron HN} and Vita Dolzan and Clint Mizzi and Kusha Kalideen and Ramesar, {Raj S.} and Milan Macek and Patrinos, {George P.} and Alessio Squassina",
year = "2016",
month = "9",
day = "1",
doi = "10.2217/pgs-2016-0015",
language = "English (US)",
volume = "17",
pages = "1533--1545",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "14",

}

TY - JOUR

T1 - Minimum information required for a DMET experiment reporting

AU - Kumuthini, Judit

AU - Mbiyavanga, Mamana

AU - Chimusa, Emile R.

AU - Pathak, Jyotishman

AU - Somervuo, Panu

AU - Van Schaik, Ron HN

AU - Dolzan, Vita

AU - Mizzi, Clint

AU - Kalideen, Kusha

AU - Ramesar, Raj S.

AU - Macek, Milan

AU - Patrinos, George P.

AU - Squassina, Alessio

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Aim: To provide pharmacogenomics reporting guidelines, the information and tools required for reporting to public omic databases. Material & methods: For effective DMET data interpretation, sharing, interoperability, reproducibility and reporting, we propose the Minimum Information required for a DMET Experiment (MIDE) reporting. Results: MIDE provides reporting guidelines and describes the information required for reporting, data storage and data sharing in the form of XML. Conclusion: The MIDE guidelines will benefit the scientific community with pharmacogenomics experiments, including reporting pharmacogenomics data from other technology platforms, with the tools that will ease and automate the generation of such reports using the standardized MIDE XML schema, facilitating the sharing, dissemination, reanalysis of datasets through accessible and transparent pharmacogenomics data reporting.

AB - Aim: To provide pharmacogenomics reporting guidelines, the information and tools required for reporting to public omic databases. Material & methods: For effective DMET data interpretation, sharing, interoperability, reproducibility and reporting, we propose the Minimum Information required for a DMET Experiment (MIDE) reporting. Results: MIDE provides reporting guidelines and describes the information required for reporting, data storage and data sharing in the form of XML. Conclusion: The MIDE guidelines will benefit the scientific community with pharmacogenomics experiments, including reporting pharmacogenomics data from other technology platforms, with the tools that will ease and automate the generation of such reports using the standardized MIDE XML schema, facilitating the sharing, dissemination, reanalysis of datasets through accessible and transparent pharmacogenomics data reporting.

KW - bioinformatics

KW - DMET

KW - minimum information requirement guidelines

KW - personalized genomics

KW - personalized medicine

KW - pharmacogenomics

KW - standardization

UR - http://www.scopus.com/inward/record.url?scp=84984985600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984985600&partnerID=8YFLogxK

U2 - 10.2217/pgs-2016-0015

DO - 10.2217/pgs-2016-0015

M3 - Article

C2 - 27548815

AN - SCOPUS:84984985600

VL - 17

SP - 1533

EP - 1545

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 14

ER -